Persistent Immune and Clotting Dysfunction Detected in Saliva and Blood Plasma after COVID-19
H. Jang, S. Choudhury, Y. Yu, B. L. Sievers, T. Gelbart, H. Singh, S. A. Rawlings, A. Proal, G. S. Tan, D. Smith, M. Freire
The paper identifies persistent immune and clotting dysfunction in saliva and plasma of COVID-19 patients 4-6 weeks post-symptom resolution, highlighting saliva as a viable alternative to plasma for monitoring immune and inflammatory sequelae.
bioRxiv · Mar 18, 2022Immunology